"Footing the Bill"
By: Marcus J. Hopkins, Blogger
"As a society we need a way of determining what is a reasonable price
at the time of introduction of a new drug," said Stephen Schondelmeyer, a
University of Minnesota professor who specializes in pharmaceutical economics.
"We have expanded coverage, but we haven't done anything to control costs
on the pricing side." (Alonso-Zaldivar, 2015)
Truer words are rarely spoken in the world of healthcare coverage. In a time
of unprecedented increases in "covered" Americans, the promised "savings"
haven't really materialized, either for payers or for consumers. Rather,
the spending on specialty medications has increased so exponentially that
both private and public payers are finding themselves faced with difficult
choices, when it comes to what coverage can be offered for the amount that
CLICK HERE to read, "Footing the Bill".
Black Market HIV/AIDS Drugs in the News, 2006 - 2013
The Partnership for Safe Medicines
The Community Access National Network (CANN) today announced that it is teaming
up with the Partnership for Safe Medicines (PSM) to better educate patients
about the risks of counterfeit or black market HIV/AIDS medicines. Since
2006, eighty-two (82) individuals have been charged with selling adulterated,
unapproved or black market medications prescribed for HIV or AIDS patients.
HERE to download, "Black Market HIV/AIDS Drugs in the News, 2006 - 2013"